CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Tezacaftor

替扎卡托 杂质对照品Tezacaftor Impurities

32 个杂质条目32 impurity entries

本页汇总 替扎卡托 的 32 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 32 impurity reference standards of Tezacaftor. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 替扎卡托(Tezacaftor)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment and Validation of a Novel Stability-Indicating RP-HPLC Method for Simultaneous Determination of Tezacaftor and Ivacaftor in Fixed Dose Combination
    Journal of chromatographic science · 2020 · Singh N et al.  ·  PMID 31953544  ·  DOI
  2. 杂质研究Impurity studiesDried Blood Spot Method Development and Clinical Validation for the Analysis of Elexacaftor, Elexacaftor-M23, Tezacaftor, Tezacaftor-M1, Ivacaftor, Ivacaftor Carboxylate, and Hydroxymethyl Ivacaftor Using LC-MS/MS
    Therapeutic drug monitoring · 2024 · Vonk SEM et al.  ·  PMID 38935410  ·  DOI
  3. 杂质研究Impurity studiesQuantitative Method for the Analysis of Ivacaftor, Hydroxymethyl Ivacaftor, Ivacaftor Carboxylate, Lumacaftor, and Tezacaftor in Plasma and Sputum Using Liquid Chromatography With Tandem Mass Spectrometry and Its Clinical Applicability
    Therapeutic drug monitoring · 2021 · Vonk SEM et al.  ·  PMID 33165217  ·  DOI
  4. 分析方法Analytical MethodsValidation of a Method for Quantifying Elexacaftor, Elexacaftor-M23, Tezacaftor, Tezacaftor-M1, and Ivacaftor by HPLC-PDA
    Drug metabolism and bioanalysis · 2026 · Sassone AH et al.  ·  PMID 42763928  ·  DOI
  5. 分析方法Analytical MethodsQuantification of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor and their active metabolites in plasma using UHPLC-MS/MS: Doors open to the application of therapeutic drug monitoring in cystic fibrosis treatment
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2025 · Wessels AMA et al.  ·  PMID 40245791  ·  DOI

替扎卡托 —— 原料药与杂质对照品Tezacaftor — drug substance & impurities

共 33 个条目(含原料药本体)33 items incl. the drug substance
Tezacaftor structure
原料药 APIAPI
替扎卡托Tezacaftor
Tezacaftor
CAS No.1152311-62-0
Chemical FormulaC26H27F3N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 1 structure
1
替扎卡托杂质1Tezacaftor Impurity 1
Tezacaftor Impurity 1
CAS No.1152311-99-3
Chemical FormulaC26H27F3N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 2 structure
2
替扎卡托杂质2Tezacaftor Impurity 2
Tezacaftor Impurity 2
CAS No.1226709-85-8
Chemical FormulaC26H27F3N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 3 structure
3
替扎卡托杂质3Tezacaftor Impurity 3
Tezacaftor Impurity 3
CAS No.1432656-98-8
Chemical FormulaC26H25F3N2O7
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 4 structure
4
替扎卡托杂质4Tezacaftor Impurity 4
Tezacaftor Impurity 4
CAS No.1432657-02-7
Chemical FormulaC26H25F3N2O7
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 5 structure
5
替扎卡托杂质5Tezacaftor Impurity 5
Tezacaftor Impurity 5
CAS No.2687976-08-3
Chemical FormulaC28H31F3N2O7
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 6 structure
6
替扎卡托杂质6Tezacaftor Impurity 6
Tezacaftor Impurity 6
CAS No.2687976-10-7
Chemical FormulaC28H31F3N2O6S
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 7 structure
7
替扎卡托杂质7Tezacaftor Impurity 7
Tezacaftor Impurity 7
CAS No.2687975-91-1
Chemical FormulaC29H31F3N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 8 structure
8
替扎卡托杂质8Tezacaftor Impurity 8
Tezacaftor Impurity 8
CAS No.2687976-09-4
Chemical FormulaC30H35F3N2O8
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 9 structure
9
替扎卡托杂质9Tezacaftor Impurity 9
Tezacaftor Impurity 9
CAS No.2669004-91-3
Chemical FormulaC33H33F3N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 10 structure
10
替扎卡托杂质10Tezacaftor Impurity 10
Tezacaftor Impurity 10
CAS No.2687975-96-6
Chemical FormulaC29H35F3N2O6Si
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 11 structure
11
替扎卡托杂质11Tezacaftor Impurity 11
Tezacaftor Impurity 11
CAS No.2516232-67-8
Chemical FormulaC33H33F3N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 12 structure
12
替扎卡托杂质12Tezacaftor Impurity 12
Tezacaftor Impurity 12
CAS No.2687976-03-8
Chemical FormulaC32H41F3N2O6Si
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 13 structure
13
替扎卡托杂质13Tezacaftor Impurity 13
Tezacaftor Impurity 13
CAS No.2687975-93-3
Chemical FormulaC28H29F3N2O7
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 14 structure
14
替扎卡托杂质14Tezacaftor Impurity 14
Tezacaftor Impurity 14
CAS No.2687976-04-9
Chemical FormulaC35H47F3N2O6Si
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 15 structure
15
替扎卡托杂质15Tezacaftor Impurity 15
Tezacaftor Impurity 15
CAS No.2687976-05-0
Chemical FormulaC34H35F3N2O7
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 16 structure
16
替扎卡托杂质16Tezacaftor Impurity 16
Tezacaftor Impurity 16
CAS No.2687975-97-7
Chemical FormulaC32H41F3N2O6Si
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 17 structure
17
替扎卡托杂质17Tezacaftor Impurity 17
Tezacaftor Impurity 17
CAS No.2516232-70-3
Chemical FormulaC34H35F3N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 18 structure
18
替扎卡托杂质18Tezacaftor Impurity 18
Tezacaftor Impurity 18
CAS No.1432657-24-3
Chemical FormulaC29H31F3N2O7
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 19 structure
19
替扎卡托杂质19Tezacaftor Impurity 19
Tezacaftor Impurity 19
CAS No.1432657-15-2
Chemical FormulaC29H31F3N2O7
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 20 structure
20
替扎卡托杂质20Tezacaftor Impurity 20
Tezacaftor Impurity 20
CAS No.1152311-57-3
Chemical FormulaC27H29F3N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 21 structure
21
替扎卡托杂质21Tezacaftor Impurity 21
Tezacaftor Impurity 21
CAS No.952661-92-6
Chemical FormulaC26H27F3N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 22 structure
22
替扎卡托杂质22Tezacaftor Impurity 22
Tezacaftor Impurity 22
CAS No.952661-80-2
Chemical FormulaC26H27F3N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 23 structure
23
替扎卡托杂质23Tezacaftor Impurity 23
Tezacaftor Impurity 23
CAS No.1419101-35-1
Chemical FormulaC26H27F3N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 24 structure
24
替扎卡托杂质24Tezacaftor Impurity 24
Tezacaftor Impurity 24
CAS No.952661-79-9
Chemical FormulaC26H27F3N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 25 structure
25
替扎卡托杂质25Tezacaftor Impurity 25
Tezacaftor Impurity 25
CAS No.2768270-29-5
Chemical FormulaC25H25F3N2O7
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 26 structure
26
替扎卡托杂质26Tezacaftor Impurity 26
Tezacaftor Impurity 26
CAS No.2010195-77-2
Chemical FormulaC25H25F3N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 27 structure
27
替扎卡托杂质27Tezacaftor Impurity 27
Tezacaftor Impurity 27
CAS No.952662-99-6
Chemical FormulaC25H25F3N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 28 structure
28
替扎卡托杂质28Tezacaftor Impurity 28
Tezacaftor Impurity 28
CAS No.2687976-23-2
Chemical FormulaC25H25F3N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 29 structure
29
替扎卡托杂质29Tezacaftor Impurity 29
Tezacaftor Impurity 29
CAS No.1294504-67-8
Chemical FormulaC29H33FN2O3
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 31 structure
31
替扎卡托杂质31Tezacaftor Impurity 31
Tezacaftor Impurity 31
CAS No.1294504-68-9
Chemical FormulaC40H39F3N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 32 structure
32
替扎卡托杂质32Tezacaftor Impurity 32
Tezacaftor Impurity 32
CAS No.3007876-86-7
Chemical FormulaC26H29F3N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Tezacaftor Impurity 33 structure
33
替扎卡托杂质33Tezacaftor Impurity 33
Tezacaftor Impurity 33
CAS No.1432656-97-7
Chemical FormulaC26H25F3N2O6
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

替扎卡托 —— 研究文献与合成路线Tezacaftor — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 替扎卡托 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Tezacaftor. Titles link to the original records; copyright remains with the authors and publishers.

合成路线文献Synthetic-route papers

  1. Organic Synthesis and Current Understanding of the Mechanisms of CFTR Modulator Drugs Ivacaftor, Tezacaftor, and Elexacaftor
    Ferreira FC, Buarque CD, Lopes-Pacheco M · Molecules (Basel, Switzerland) · 2024

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

替扎卡托 杂质谱研究要点Tezacaftor — impurity profiling notes

下面这些是拿到 替扎卡托 的 33 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 33 impurity entries for Tezacaftor, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances